Lung cancer screening with low-dose thoracic CT-scan in the Somme area

被引:6
作者
Leleu, O. [1 ]
Auquier, M. [2 ]
Carre, O. [3 ]
Chauffert, B. [4 ]
Dubreuil, A. [5 ]
Petigny, V. [5 ]
Trancart, B. [6 ]
Berna, P. [7 ]
Jounieaux, V. [8 ]
机构
[1] Ctr Hosp Abbeville, Serv Pneumol, 43 Rue Isle, F-80100 Abbeville, France
[2] CHU Amiens, Serv Radiol, F-80000 Amiens, France
[3] Clin Europe, Serv Pneumol, 5 Allee Pays Bas, F-80000 Amiens, France
[4] CHU Amiens, Serv Oncol Med, F-80000 Amiens, France
[5] Assoc Depistage Malad Somme ADEMA80, 7 Rue Jean Calvin, F-80000 Amiens, France
[6] Clin St Isabelle, Serv Radiol, 236 Route Amiens, F-80103 Abbeville, France
[7] CHU Amiens, Serv Chirurg Thorac, F-80000 Amiens, France
[8] CHU Amiens, Serv Pneumol & Reanimat Resp, F-80000 Amiens, France
关键词
Lung cancer; Screening; Low radiation scanner; Smoking cessation; STATEMENT; PROJECT;
D O I
10.1016/j.rmr.2016.08.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale. This feasibility trial proposes to set up in the department of the Somme an annual screening for lung cancer with low-dose thoracic CT. It responds to the first objective of the third cancer plan and follows the publication of the results of the National Lung Screening Trial in 2011. Methods. The method of this study is to use the existing networks among and between healthcare professionals and the departmental cancer screening structure. The inclusion criteria will be those of the National Lung Screening Trial. Screening will be proposed by treating physicians and chest physicians. The CT-scan will be performed in radiological centers that adhere to the good practice charter for low radiation scanning. A copy of CT results will be sent to the departmental structure of cancer screening (ADEMA80) which will ensure traceability and will perform statistical analysis. The study received funding from the Agence regionale de sante de la Picardie and la ligue contre le cancer. Expected results. The primary endpoints of this screening will be the number of cancers diagnosed and the survival of the patients. The follow-up of positive examinations, delays in management and the level of participation will also be assessed. (C) 2016 SPLF. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:262 / 267
页数:6
相关论文
共 12 条
  • [1] Results of the Two Incidence Screenings in the National Lung Screening Trial
    Aberle, Denise R.
    DeMello, Sarah
    Berg, Christine D.
    Black, William C.
    Brewer, Brenda
    Church, Timothy R.
    Clingan, Kathy L.
    Duan, Fenghai
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine A.
    Gierada, David S.
    Jain, Amanda
    Jones, Gordon C.
    Mahon, Irene
    Marcus, Pamela M.
    Rathmell, Joshua M.
    Sicks, JoRean
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (10) : 920 - 931
  • [2] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Black, William C.
    Clapp, Jonathan D.
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine
    Marcus, Pamela M.
    Sicks, JoRean D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) : 395 - 409
  • [3] [Anonymous], 2006, OBSERVATOIRE REGIONA, P5
  • [4] From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)
    Couraud, S.
    Cortot, A. B.
    Greillier, L.
    Gounant, V.
    Mennecier, B.
    Girard, N.
    Besse, B.
    Brouchet, L.
    Castelnau, O.
    Frappe, P.
    Ferretti, G. R.
    Guittet, L.
    Khalil, A.
    Lefebure, P.
    Laurent, F.
    Liebart, S.
    Molinier, O.
    Quoix, E.
    Revel, M. -P.
    Stach, B.
    Souquet, P. -J.
    Thomas, P.
    Tredaniel, J.
    Lemarie, E.
    Zalcman, G.
    Barlesi, F.
    Milleron, B.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (03) : 586 - 597
  • [5] Duchemann B, 2015, REV MAL RESPIR, V7, P245
  • [6] CT screening for lung cancer: countdown to implementation
    Field, John K.
    Hansell, David M.
    Duffy, Stephen W.
    Baldwin, David R.
    [J]. LANCET ONCOLOGY, 2013, 14 (13) : E591 - E600
  • [7] FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO
  • [8] 2-0
  • [9] Early Lung Cancer Action Project: overall design and findings from baseline screening
    Henschke, CI
    McCauley, DI
    Yankelevitz, DF
    Naidich, DP
    McGuinness, G
    Miettinen, OS
    Libby, DM
    Pasmantier, MW
    Koizumi, J
    Altorki, NK
    Smith, JP
    [J]. LANCET, 1999, 354 (9173) : 99 - 105
  • [10] Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476